Research Article

Exposure to Mebendazole and Pyrvinium during Pregnancy: A Danish Nationwide Cohort Study

Table 1

Characteristics of exposed and unexposed women.

Drug exposurePyrvinium (%)Mebendazole (%)Both drugs (%)Unexposed (%)

Age
 <2033 (2.5)28 (1.1)4 (0.8)19 649 (2.8)
 20–24178 (11.1)209 (8.1)43 (8.1)111 765 (15.7)
 25–29501 (31.2)772 (30.0)147 (27.5)274 107 (38.4)
 30–34637 (39.7)1069 (41.5)230 (43.1)224 422 (31.4)
 >35257 (16.0)497 (19.3)110 (20.6)84 242 (11.8)
value*

Income
 Quartile 1398 (24.8)655 (25.4)119 (22.3)178476 (25.0)
 Quartile 2385 (24.0)680 (26.4)117 (21.9)178466 (25.0)
 Quartile 3428 (26.7)614 (23.8)140 (26.2)178466 (25.0)
 Quartile 4395 (24.6)877 (24.3)158 (29.6)178470 (25.0)
value*

Parity
 0309 (19.2)229 (8.9)55 (10.3)310 740 (43.5)
 1574 (35.7)860 (33.4)172 (32.2)266754 (37.4)
 2499 (31.1)959 (37.2)209 (39.1)100 523 (14.1)
 >2224 (14.0)527 (20.5)98 (18.4)36 152 (5.1)
value*

Education class
 Low566 (35.8)908 (35.8)176 (33.3)241803 (35.3)
 Medium492 (31.1)747 (29.4)144 (27.3)222398 (32.4)
 High522 (33.0)883 (34.8)208 (39.4)221316 (32.3)
value*

Smoking
 Yes266 (18.0)435 (18.3)91 (18.4)121178 (18.2)
 No1215 (82.0)1948 (81.8)405 (81.7)544192 (81.8)
value*

The values are results of χ 2 tests comparing each exposure group with the unexposed group.